Funding
Who raised, when, and from whom? Explore announced rounds, including emerging Indian companies, and company-reported SEC notices. Each amount keeps its original source and date.
1,559 filings · Form D notices of private raises, 2024-01-02 to 2026-03-31
Resolute Science, Inc.Biotechnology
San Diego, California · founded 2020 · Convertible · 1 investors · Andre Basbaum, Faith Barnett
Phythera Therapeutics Inc.Biotechnology
Irvine, California · founded 2021 · Equity · 10 investors · Ngoc Tran, Igor Nasonkin, Ph.D.
TheRas, Inc.Biotechnology
Palo Alto, California · Equity · 15 investors · Michelle Doig, Idan Elmelech
Aardvark Therapeutics, Inc.Biotechnology
San Diego, California · Equity · 31 investors · Jeffrey Chi, Victor Tong
Entact Bio, Inc.Biotechnology
Watertown, Massachusetts · founded 2021 · Equity · 7 investors · Victoria Richon, Owen Smith
Zenas BioPharma, Inc.Biotechnology
Waltham, Massachusetts · founded 2023 · Equity, Convertible · 26 investors · Patrick Enright, Tomas Kiselak
Medicenna Therapeutics Corp.Biotechnology
Toronto, Ontario, Canada · Equity, Options, Convertible, The Company issued 5,141,388 pre-funded warrants t · 1 investors · John Sampson, Rosemina Merchant
Stingray Therapeutics, Inc.Biotechnology
Dallas, Texas · Options, Convertible · 1 investors · Jonathan Northrup, Sunil Sharma
Ajax Therapeutics, Inc.Biotechnology
New York, New York · founded 2019 · Equity · 21 investors · Martin Vogelbaum, Ross Levine
Smart Health Diagnostics CoBiotechnology
Irvine, California · Debt, Options · 64 investors · Darin Nelson, Susie Lu
Oculogica, Inc.Biotechnology
New Richmond, Wisconsin · Equity · 24 investors · Jim Flannigan, Kathryn Swintek
Virica Biotech Inc.Biotechnology
Ottawa, Ontario, Canada · Equity · 2 investors · Daniella Kranjac, Susan Dexter
Nectero Medical IncBiotechnology
Tempe, Arizona · Equity, Series D Preferred Stock · 30 investors · Anil Dasu, Colin Morrison
MAINZ BIOMED N.V.Biotechnology
Mainz, Germany · founded 2021 · Equity, Debt, Options, Convertible · 1 investors · Phillip Freese, Gregory Tibbits
PALISADE BIO, INC.Biotechnology
Carlsbad, California · Equity, Options, Convertible · 1 investors · Binxian Wei, J.D. Finley
StimuSIL, Inc.Biotechnology
Wilmington, Delaware · founded 2021 · Equity · 7 investors · Firat Yerlikaya, Pablo Villalba
OverT Bio, Inc.Biotechnology
New York, New York · founded 2022 · Equity · 15 investors · Mateusz Legut, Vasudev Bailey
Penderia Technologies, Inc.Biotechnology
Eugene, Oregon · founded 2020 · SAFE (Simple Agreement for Future Equity) · 3 investors · Robert Guldberg, Michael McGeehan
GlucoTrack, Inc.Biotechnology
Rutherford, New Jersey · Equity · 9 investors · Paul Goode, Shimon Rapps
Iambic Therapeutics, Inc.Biotechnology
San Diego, California · founded 2019 · Equity · 8 investors · William Rastetter, Kurt von Emster
Cidara Therapeutics, Inc.Biotechnology
San Diego, California · Equity · 7 investors · Carin Canale-Theakston, Theodore Schroeder
Zura Bio LtdBiotechnology
Henderson, Nevada · founded 2021 · Equity, Options, Convertible · 19 investors · Michael Howell, Sandeep Kulkarni
inSoma Bio, Inc.Biotechnology
Durham, North Carolina · Equity, Amounts exclude the value of securities that automatically converted in · 16 investors · June Almenoff, Stefan Roberts
Endeavor Biomedicines, Inc.Biotechnology
San Diego, California · Equity · 32 investors · Patrick Enright, Bernard Davitian
IMMUNOPROFILE, LLCBiotechnology
Marco Island, Florida · Equity · 3 investors · William Shea, Sudip Ghatak
CIRC Biosciences, Inc.Biotechnology
Chicago, Illinois · founded 2019 · Debt · 19 investors · Darien Parhad, Timothy Cunniff
JelliSee Ophthalmics Inc.Biotechnology
Mclean, Virginia · founded 2019 · Debt, Options · 34 investors · Jerry Arthur, Michael Malesardi
AsclepiX Therapeutics, Inc.Biotechnology
Bethesda, Maryland · founded 2023 · Equity · 9 investors · Robert Dempsey, Steven Altschuler
BIO-PATH HOLDINGS, INC.Biotechnology
Bellaire, Texas · Options, Convertible · 3 investors · Peter Nielsen, Heath Cleaver
EpiBiologics, Inc.Biotechnology
San Mateo, California · founded 2021 · Equity · 15 investors · Jason Coloma, Ann Lee-Karlon